![Damien McDevitt](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Damien McDevitt
Directeur Général chez
ASPEN NEUROSCIENCE, INC.
Fortune : 8 M $ au 30/09/2026
Profil
Dr. Damien McDevitt is a President, Chief Executive Officer & Director at Aspen Neuroscience, Inc. He is on the Board of Directors at Aspen Neuroscience, Inc. Dr. McDevitt was previously employed as a Chief Executive Officer & Director by Akcea Therapeutics, Inc., a Chief Business Officer by Ionis Pharmaceuticals, Inc., a Senior Vice President-Corporate Development by ACADIA Pharmaceuticals, Inc., and a Vice President by GlaxoSmithKline LLC.
He received his undergraduate degree from Trinity College Dublin and a doctorate degree from Trinity College Dublin.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
| 29/10/2026 | 561 648 ( 2,85% ) | 8 M $ | 30/09/2026 |
Postes actifs de Damien McDevitt
| Sociétés | Poste | Début |
|---|---|---|
| ASPEN NEUROSCIENCE, INC. | Directeur Général | 25/01/2021 |
Anciens postes connus de Damien McDevitt
| Sociétés | Poste | Fin |
|---|---|---|
| AKCEA THERAPEUTICS, INC. | Directeur Général | 01/01/2020 |
| IONIS PHARMACEUTICALS, INC. | Corporate Officer/Principal | 01/09/2019 |
| ACADIA PHARMACEUTICALS INC. | Corporate Officer/Principal | 01/06/2018 |
GlaxoSmithKline LLC
 GlaxoSmithKline LLC Pharmaceuticals: MajorHealth Technology Engages in research and development, manufacturing of respiratory, immunology, oncology and infectious disease medicines and vaccines | Corporate Officer/Principal | 01/11/2017 |
Formation de Damien McDevitt
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
82
Relations au 1er degré
6
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 6 |
|---|---|
Ionis Pharmaceuticals, Inc.
 Ionis Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Discovers and develops antisense drugs | Health Technology |
ACADIA Pharmaceuticals, Inc.
 ACADIA Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops pharmaceuticals drugs for treatment of central nervous system disorders | Health Technology |
Trinity College Dublin
 Trinity College Dublin Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
GlaxoSmithKline LLC
GlaxoSmithKline LLC Pharmaceuticals: MajorHealth Technology Engages in research and development, manufacturing of respiratory, immunology, oncology and infectious disease medicines and vaccines | Health Technology |
Akcea Therapeutics, Inc.
 Akcea Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Discovers and develops drugs for cardiometabolic lipid disorders | Health Technology |
Aspen Neuroscience, Inc.
 Aspen Neuroscience, Inc. BiotechnologyHealth Technology Operates as a clinical-stage regenerative medicine biotechnology company and develops autologous induced-pluripotent stem cell | Health Technology |
